Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole

Triclabendazole progress report, 2005–2009: an advancement of learning?

(2009) I. Fairweather   JOURNAL OF HELMINTHOLOGY

A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica

(2009) E. TONER et al.   PARASITOLOGY

Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha

(2009) M. McConville et al.   PARASITOLOGY RESEARCH

LC–MS–MS identification of albendazole and flubendazole metabolites formed ex vivo by Haemonchus contortus

(2008) Viktor Cvilink et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep

(2008) G. VIRKEL et al.   JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS

Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica

(2008) C. DEVINE et al.   PARASITOLOGY

Phase I biotransformation of albendazole in lancet fluke (Dicrocoelium dendriticum)

(2008) V. Cvilink et al.   RESEARCH IN VETERINARY SCIENCE

Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica

(2008) L. Halferty et al.   VETERINARY PARASITOLOGY

Albendazole enantiomeric metabolism and binding to cytosolic proteins in the liver fluke Fasciola hepatica

(2008) H. Solana et al.   VETERINARY RESEARCH COMMUNICATIONS

Changes to oxfendazole chiral kinetics and anthelmintic efficacy induced by piperonyl butoxide in horses

(2007) S. F. SÁNCHEZ BRUNI et al.   EQUINE VETERINARY JOURNAL